Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
PNFP
|
David B Ingram
Director |
SELL
Open market or private sale
|
Direct | 10,309 Reduced 11.14% |
$1,298,934
$126.0 p/Share
|
Jan 30
2025 |
EQBK
|
Krzysztof Slupkowski
Chief Credit Officer |
SELL
Open market or private sale
|
Direct | 64 Reduced 0.61% |
$2,786
$43.54 p/Share
|
Jan 30
2025 |
EQBK
|
Julie A Huber
COO and EVP |
SELL
Open market or private sale
|
Direct | 317 Reduced 0.56% |
$13,802
$43.54 p/Share
|
Jan 30
2025 |
SGA
|
Edward K. Christian Trust |
SELL
Open market or private sale
|
Direct | 106 Reduced 0.01% |
$1,327
$12.52 p/Share
|
Jan 30
2025 |
KGS
|
Frontier Top Co Partnership, L.P. |
SELL
Open market or private sale
|
Indirect | 3,728,677 Reduced 0.0% |
$177,112,157
$47.5 p/Share
|
Jan 30
2025 |
DBX
|
Timothy Regan
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.62% |
$80,425
$32.17 p/Share
|
Jan 30
2025 |
ACR-PD
|
Eagle Point Credit Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 811 Reduced 0.0% |
$20,193
$24.9 p/Share
|
Jan 30
2025 |
PBF
|
Control Empresarial De Capitales S.A. De C.V. |
BUY
Open market or private purchase
|
Direct | 46,000 Added 0.16% |
$1,366,200
$29.7 p/Share
|
Jan 30
2025 |
BEAM
|
John M. Evans
CEO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 3.2% |
$810,600
$27.02 p/Share
|
Jan 30
2025 |
AGNC
|
Bernice Bell
EVP, CFO |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 3.37% |
$130,650
$10.05 p/Share
|
Jan 30
2025 |
SNX
|
Patrick Zammit
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 6,823 Reduced 3.96% |
$975,689
$143.0 p/Share
|
Jan 30
2025 |
RMT
|
Charles M Royce |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 7.87% |
$994,999
$9.95 p/Share
|
Jan 30
2025 |
HQL
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 21,835 Reduced 0.0% |
$309,183
$14.16 p/Share
|
Jan 30
2025 |
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 16,600 Reduced 0.0% |
$201,026
$12.11 p/Share
|
Jan 30
2025 |
BOKF
|
Steven Bangert
Director |
BUY
Open market or private sale
|
Indirect | 1,250 Added 0.0% |
$139,762
$111.81 p/Share
|
Jan 30
2025 |
BOKF
|
Steven Bangert
Director |
BUY
Open market or private sale
|
Direct | 1,750 Added 3.91% |
$195,720
$111.84 p/Share
|
Jan 30
2025 |
BCAT
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 200 Reduced 0.0% |
$3,116
$15.58 p/Share
|
Jan 30
2025 |
MPA
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,210 Reduced 0.0% |
$61,686
$11.84 p/Share
|
Jan 30
2025 |
ENX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,084 Added 0.0% |
$39,247
$9.61 p/Share
|
Jan 30
2025 |
BFZ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 28,171 Reduced 0.0% |
$316,642
$11.24 p/Share
|
Jan 30
2025 |
DRI
|
Douglas J. Milanes
SVP, Chief Supply Chain Ofcr |
SELL
Open market or private sale
|
Direct | 7,892 Reduced 66.85% |
$1,546,437
$195.95 p/Share
|
Jan 30
2025 |
WSBF
|
Stephen J Schmidt
Director |
SELL
Open market or private sale
|
Direct | 12,291 Reduced 14.92% |
$171,336
$13.94 p/Share
|
Jan 30
2025 |
WSBF
|
Kristine A Rappe
Director |
SELL
Open market or private sale
|
Direct | 13,931 Reduced 33.77% |
$193,501
$13.89 p/Share
|
Jan 30
2025 |
CHCO
|
David L Bumgarner
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 556 Reduced 5.59% |
$66,720
$120.0 p/Share
|
Jan 30
2025 |
SMG
|
Christopher Hagedorn
EVP & Chief of Staff |
SELL
Open market or private sale
|
Direct | 3,568 Reduced 5.99% |
$255,968
$71.74 p/Share
|
Jan 30
2025 |
SMG
|
James Hagedorn
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 142,733 Reduced 61.78% |
$10,208,264
$71.52 p/Share
|
Jan 30
2025 |
PDEX
|
Raymond E Cabillot
Director |
SELL
Open market or private sale
|
Indirect | 1,100 Reduced 0.0% |
$49,511
$45.01 p/Share
|
Jan 30
2025 |
USEG
|
Ryan Lewis Smith
CEO |
BUY
Open market or private purchase
|
Direct | 500 Added 0.06% |
$1,110
$2.22 p/Share
|
Jan 30
2025 |
TEM
|
Eric P Lefkofsky
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 77,626 Reduced 1.36% |
$4,240,708
$54.63 p/Share
|
Jan 30
2025 |
ATEC
|
Patrick Miles
CEO |
SELL
Open market or private sale
|
Direct | 43,313 Reduced 0.7% |
$521,055
$12.03 p/Share
|
Jan 30
2025 |
ALKS
|
Craig C. Hopkinson
EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 100,918 Reduced 69.5% |
$3,234,421
$32.05 p/Share
|
Jan 30
2025 |
BOH
|
Taryn L Salmon
Vice Chair |
SELL
Open market or private sale
|
Direct | 449 Reduced 4.35% |
$33,661
$74.97 p/Share
|
Jan 30
2025 |
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,587 Reduced 0.1% |
$117,833
$11.13 p/Share
|
Jan 30
2025 |
WEAV
|
Blake G Modersitzki |
SELL
Open market or private sale
|
Indirect | 59,964 Reduced 0.0% |
$990,005
$16.51 p/Share
|
Jan 30
2025 |
HOPE
|
Thomas Stenger
SEVP, Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 4,185 Reduced 17.84% |
$49,508
$11.83 p/Share
|
Jan 30
2025 |
PLXS
|
Angelo Michael Ninivaggi Jr
Exec VP, CAO, Gen Coun & Secy |
SELL
Open market or private sale
|
Direct | 3,423 Reduced 10.4% |
$498,388
$145.6 p/Share
|
Jan 30
2025 |
ABT
|
Hubert L Allen
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 58,428 Reduced 24.02% |
$7,482,873
$128.07 p/Share
|
Jan 30
2025 |
NPCE
|
Martha Morrell
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.23% |
$3,000
$15.0 p/Share
|
Jan 30
2025 |
BENF
|
Jeff Welday
Officer |
SELL
Open market or private sale
|
Direct | 306 Reduced 0.2% |
$189
$0.62 p/Share
|
Jan 30
2025 |
CDXS
|
Opaleye Management Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 0.0% |
$89,800
$4.49 p/Share
|
Jan 30
2025 |
ABT
|
Daniel Gesua Sive Salvadori
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 23,771 Reduced 15.9% |
$3,054,573
$128.5 p/Share
|
Jan 30
2025 |
NTRS
|
Jason J. Tyler
President/Wealth Management |
SELL
Open market or private sale
|
Direct | 2,237 Reduced 3.69% |
$252,042
$112.67 p/Share
|
Jan 30
2025 |
AUBN
|
David E Housel |
BUY
Open market or private purchase
|
Direct | 200 Added 2.4% |
$4,384
$21.92 p/Share
|
Jan 30
2025 |
ALK
|
Andrea L Schneider
SVP PEOPLE |
SELL
Open market or private sale
|
Direct | 1,830 Reduced 8.27% |
$134,175
$73.32 p/Share
|
Jan 30
2025 |
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,120,049
$266.74 p/Share
|
Jan 30
2025 |
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,120,049
$266.74 p/Share
|
Jan 30
2025 |
TDUP
|
Patricia Nakache |
SELL
Open market or private sale
|
Indirect | 79,223 Reduced 0.0% |
$175,082
$2.21 p/Share
|
Jan 30
2025 |
BLK
|
J. Richard Kushel
Senior Managing Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 12.75% |
$10,727,600
$1072.76 p/Share
|
Jan 30
2025 |
SANM
|
Eugene A Delaney
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 11.48% |
$835,000
$83.5 p/Share
|
Jan 30
2025 |
MTACW
|
Mary T Szela
CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct | 5,010 Added 1.12% |
$26,452
$5.28 p/Share
|
Jan 30
2025 |